325 related articles for article (PubMed ID: 23934709)
21. Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trial.
Yerasi C; Baker NC; Jonnalagadda AK; Torguson R; Singh S; Vies J; Waksman R
J Am Soc Hypertens; 2015 Dec; 9(12):959-65. PubMed ID: 26687550
[TBL] [Abstract][Full Text] [Related]
22. Renal denervation in resistant hypertension: a review of clinical trials and future perspectives.
Yamamoto E; Sueta D; Tsujita K
Cardiovasc Interv Ther; 2022 Jul; 37(3):450-457. PubMed ID: 35474179
[TBL] [Abstract][Full Text] [Related]
23. Anatomical eligibility of the renal vasculature for catheter-based renal denervation in hypertensive patients.
Rimoldi SF; Scheidegger N; Scherrer U; Farese S; Rexhaj E; Moschovitis A; Windecker S; Meier B; Allemann Y
JACC Cardiovasc Interv; 2014 Feb; 7(2):187-192. PubMed ID: 24440022
[TBL] [Abstract][Full Text] [Related]
24. Renal denervation for resistant hypertension: yes.
Boschetti E; Alrashdi Y; Schillaci G
Intern Emerg Med; 2016 Jun; 11(4):491-3. PubMed ID: 26970989
[TBL] [Abstract][Full Text] [Related]
25. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.
Mahfoud F; Urban D; Teller D; Linz D; Stawowy P; Hassel JH; Fries P; Dreysse S; Wellnhofer E; Schneider G; Buecker A; Schneeweis C; Doltra A; Schlaich MP; Esler MD; Fleck E; Böhm M; Kelle S
Eur Heart J; 2014 Sep; 35(33):2224-31b. PubMed ID: 24603307
[TBL] [Abstract][Full Text] [Related]
26. [Renal artery denervation for treating refractory hypertension].
Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
[TBL] [Abstract][Full Text] [Related]
27. Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials.
Kjeldsen SE; Narkiewicz K; Oparil S; Hedner T
Blood Press; 2014 Jun; 23(3):135-7. PubMed ID: 24842262
[No Abstract] [Full Text] [Related]
28. SYMPLICITY HTN-Japan - First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients - .
Kario K; Ogawa H; Okumura K; Okura T; Saito S; Ueno T; Haskin R; Negoita M; Shimada K;
Circ J; 2015; 79(6):1222-9. PubMed ID: 25912693
[TBL] [Abstract][Full Text] [Related]
29. The Prevalence of Japanese Outpatients with Hypertension Who Meet the Definition of Treatment Resistant Hypertension and Are Eligible for Enrolment in Clinical Trials of Endovascular Ultrasound Renal Denervation.
Okamura K; Shirai K; Okuda T; Urata H
Intern Med; 2018 Jan; 57(1):1-12. PubMed ID: 29033430
[TBL] [Abstract][Full Text] [Related]
30. High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3.
Waksman R; Bakris GL; Steinvil A; Garcia-Garcia H; Brown AL; DiFilippo W; Scott T; Singh J; DeBruin V; Jones D; Jolivette D; Bhatt DL
Am Heart J; 2017 Oct; 192():76-84. PubMed ID: 28938966
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study.
Brambilla G; Bombelli M; Seravalle G; Cifkova R; Laurent S; Narkiewicz K; Facchetti R; Redon J; Mancia G; Grassi G
J Hypertens; 2013 Oct; 31(10):2018-24. PubMed ID: 23838657
[TBL] [Abstract][Full Text] [Related]
32. Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.
Dorenkamp M; Bonaventura K; Leber AW; Boldt J; Sohns C; Boldt LH; Haverkamp W; Frei U; Roser M
Eur Heart J; 2013 Feb; 34(6):451-61. PubMed ID: 23091202
[TBL] [Abstract][Full Text] [Related]
33. Renal denervation in patients with resistant hypertension: six-month results.
Dores H; de Sousa Almeida M; de Araújo Gonçalves P; Branco P; Gaspar A; Sousa H; Canha Gomes A; Andrade MJ; Carvalho MS; Campante Teles R; Raposo L; Mesquita Gabriel H; Pereira Machado F; Mendes M
Rev Port Cardiol; 2014 Apr; 33(4):197-204. PubMed ID: 24472425
[TBL] [Abstract][Full Text] [Related]
34. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension.
Ukena C; Mahfoud F; Spies A; Kindermann I; Linz D; Cremers B; Laufs U; Neuberger HR; Böhm M
Int J Cardiol; 2013 Sep; 167(6):2846-51. PubMed ID: 22917547
[TBL] [Abstract][Full Text] [Related]
35. Renal denervation in treatment-resistant hypertension: a reappraisal.
Persu A; Jin Y; Fadl Elmula FE; Renkin J; Høieggen A; Kjeldsen SE; Staessen JA
Curr Opin Pharmacol; 2015 Apr; 21():48-52. PubMed ID: 25601357
[TBL] [Abstract][Full Text] [Related]
36. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
[TBL] [Abstract][Full Text] [Related]
37. [Frequency of hypertension resistant to treatment and indication for renal denervation].
Rosenbaum D; Villeneuve F; Gury C; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):229-33. PubMed ID: 22677181
[TBL] [Abstract][Full Text] [Related]
38. Renal denervation in multiple renal arteries.
Verloop WL; Vink EE; Spiering W; Blankestijn PJ; Doevendans PA; Bots ML; Vonken EJ; Voskuil M
Eur J Clin Invest; 2014 Aug; 44(8):728-35. PubMed ID: 24931208
[TBL] [Abstract][Full Text] [Related]
39. Expanding the indication spectrum: renal denervation in diabetes.
Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
[TBL] [Abstract][Full Text] [Related]
40. High incidence of secondary hypertension in patients referred for renal denervation--the Copenhagen experience.
Olsen LK; Kamper AL; Svendsen JH; Bang LE; Frimodt-Møller M; Kelbæk H; Sander M; Feldt-Rasmussen B
Blood Press; 2014 Aug; 23(4):233-9. PubMed ID: 24437697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
